VRTX

Vertex Pharmaceuticals

D
VRTX
USD
-7.14
(-1.4842%)
Market Closed
38,458.00
Volume
0.3
EPS
-
Div Yield
-240.247470
P/E
122,322,377,067.79
Market Cap
Today
-1.4842%
1 Week
-0.219%
1 Month
-0.721%
6 Months
15.241%
12 Months
34.628%
Year To Date
16.393%
All Time
0%

Title:
Vertex Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Vertex Pharmaceuticals is an American biopharmaceutical company in the business of researching, developing, manufacturing and marketing small molecule drugs for human patients with serious diseases. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, Massachusetts. Some of the diseases impacted by its therapies include cystic fibrosis; infectious diseases, including viral infections, such as influenza and bacterial infections; rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders. The company was one of the early pioneers of rational drug design rather than combinatorial chemistry.
Do you need help or have a question?